GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Eosinophil Recruitment and Activation in Solid Tumors

$302,789
James Joseph Lee · Mayo Clinic Arizona · R01 · FY2006 · CA

Tissue and Pathology Core

$302,738
Massimo F Loda · Dana-Farber Cancer Inst · P50 · FY2013 · CA

Biomarkers and Therapeutic Targets in Pancreatic Cancer

$302,724
Brigham And Women'S Hospital · R01 · FY2005 · CA

Kras-Induced Cellular Plasticity in Pancreatic Cancer

$302,482
Stephen F Konieczny · Purdue University · R01 · FY2011 · CA

Role of PKC iota in metaplasia and initiation of pancreatic cancer

$302,328
Nicole R Murray · Mayo Clinic Jacksonville · R01 · FY2013 · CA

Targeting a non-canonical RAS-driven pathway in pancreatic cancer

$302,328
David A Cheresh · University Of California, San Diego · R01 · FY2013 · CA

Sindbis Vectors For Advanced Pancreatic Cancer Therapy

$302,318
New York University School Of Medicine · R01 · FY2005 · CA

Mechanisms & Therapeutic Targeting of the Microenvironment in Pancreatic Cancer

$302,018
Douglas Hanahan · Dana-Farber Cancer Inst · P01 · FY2009 · CA

VisualSonics Vevo 3100 High-Frequency Ultrasound Imaging System

$301,950
John A Auchampach · Medical College Of Wisconsin · S10 · FY2019 · OD

Ligand-Receptor Interactions in the TGF-beta superfamily

$301,930
Andrew P Hinck · University Of Texas Hlth Science Center · R01 · FY2009 · GM

Role of Dietary Zinc Transporter ZIP4 in Pancreatic Cancer

$301,913
Min Li · University Of Texas Hlth Sci Ctr Houston · R01 · FY2012 · CA

Role of Dietary Zinc Transporter ZIP4 in Pancreatic Cancer

$301,913
Min Li · University Of Texas Hlth Sci Ctr Houston · R01 · FY2011 · CA

Analysis of Patient Tumor Responses to Apo2L/TRAIL

$301,909
Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2008 · CA

Enhancing the Biomedical Computing Platform for Pancreatic Cancer Research

$301,877
Simon Sherman · University Of Nebraska Medical Center · R01 · FY2011 · CA

Study of Epigenetic Marks in Human Islet-derived Pancreatic Precursor Cells

$301,723
Marvin Gershengorn · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK

Overcoming pancreatic tumor resistance to gemcitabine

$301,641
Zhengrong Cui · University Of Texas At Austin · R01 · FY2014 · CA

PDX Core

$301,629
Jennifer E Koblinski · Virginia Commonwealth University · U54 · FY2024 · CA

JAK1 Signaling in Pancreatic Cancer Initiation and Progression

$301,594
Kay-Uwe Wagner · Wayne State University · R01 · FY2019 · CA

Develop and High-Throughput Screening of Targeted Anticancer Nanomedicines

$301,572
Valery A Petrenko · Northeastern University · U54 · FY2011 · CA

Regulation and targeting of tumor cell states and plasticity in pancreatic cancer

$301,496
Srivatsan Raghavan · Dana-Farber Cancer Inst · K08 · FY2025 · CA

Regulation and targeting of tumor cell states and plasticity in pancreatic cancer

$301,496
Srivatsan Raghavan · Dana-Farber Cancer Inst · K08 · FY2023 · CA

Regulation and targeting of tumor cell states and plasticity in pancreatic cancer

$301,496
Srivatsan Raghavan · Dana-Farber Cancer Inst · K08 · FY2024 · CA

Mechanisms of Carcinogenesis in BRCA2 Mutant Cells

$301,490
Vanderbilt University · R01 · FY2001 · CA

Exploiting new approaches for selective inhibition of trypsins

$301,404
Evette S Radisky · Mayo Clinic Jacksonville · R01 · FY2022 · GM

TK-based methods to improve radioimmunotherapy

$301,350
University Of Nebraska Medical Center · R01 · FY2005 · CA